Role of self-irradiation defects on the ageing of 239PuCoGa5

6 pages, 18 referencesInternational audienceLow-temperature accumulation and annealing experiments, in conjunction with electrical resistivity and critical current density measurements, were used to study the ageing of the actinide superconductor PuCoGa5. These measurements reveal that 2-nm sized non-superconducting point-like regions are the main damage formed during room temperature ageing; smaller point-like defect were irrelevant to transport properties. Defect sizes and densities deduced from experiment agree with Transmission Electron Micoscopy observations

Oral Abstracts 7: RA ClinicalO37. Long-Term Outcomes of Early RA Patients Initiated with Adalimumab Plus Methotrexate Compared with Methotrexate Alone Following a Targeted Treatment Approach

Background: This analysis assessed, on a group level, whether there is a long-term advantage for early RA patients treated with adalimumab (ADA) + MTX vs those initially treated with placebo (PBO) + MTX who either responded to therapy or added ADA following inadequate response (IR). Methods: OPTIMA was a 78- week, randomized, controlled trial of ADA + MTX vs PBO + MTX in MTX-naïve early (<1 year) RA patients. Therapy was adjusted at week 26: ADA + MTX-responders (R) who achieved DAS28 (CRP) <3.2 at weeks 22 and 26 (Period 1, P1) were re-randomized to withdraw or continue ADA and PBO + MTX-R continued randomized therapy for 52 weeks (P2); IR-patients received open-label (OL) ADA + MTX during P2. This post hoc analysis evaluated the proportion of patients at week 78 with DAS28 (CRP) <3.2, HAQ-DI <0.5, and/or ΔmTSS ≤0.5 by initial treatment. To account for patients who withdrew ADA during P2, an equivalent proportion of R was imputed from ADA + MTX-R patients. Results: At week 26, significantly more patients had low disease activity, normal function, and/or no radiographic progression with ADA + MTX vs PBO + MTX (Table 1). Differences in clinical and functional outcomes disappeared following additional treatment, when PBO + MTX-IR (n = 348/460) switched to OL ADA + MTX. Addition of OL ADA slowed radiographic progression, but more patients who received ADA + MTX from baseline had no radiographic progression at week 78 than patients who received initial PBO + MTX. Conclusions: Early RA patients treated with PBO + MTX achieved comparable long-term clinical and functional outcomes on a group level as those who began ADA + MTX, but only when therapy was optimized by the addition of ADA in PBO + MTX-IR. Still, ADA + MTX therapy conferred a radiographic benefit although the difference did not appear to translate to an additional functional benefit. Disclosures: P.E., AbbVie, Merck, Pfizer, UCB, Roche, BMS—Provided Expert Advice, Undertaken Trials, AbbVie—AbbVie sponsored the study, contributed to its design, and participated in the collection, analysis, and interpretation of the data, and in the writing, reviewing, and approval of the final version. R.F., AbbVie, Pfizer, Merck, Roche, UCB, Celgene, Amgen, AstraZeneca, BMS, Janssen, Lilly, Novartis—Research Grants, Consultation Fees. S.F., AbbVie—Employee, Stocks. A.K., AbbVie, Amgen, AstraZeneca, BMS, Celgene, Centocor-Janssen, Pfizer, Roche, UCB—Research Grants, Consultation Fees. H.K., AbbVie—Employee, Stocks. S.R., AbbVie—Employee, Stocks. J.S., AbbVie, Amgen, AstraZeneca, BMS, Celgene, Centocor-Janssen, GlaxoSmithKline, Lilly, Pfizer (Wyeth), MSD (Schering-Plough), Novo-Nordisk, Roche, Sandoz, UCB—Research Grants, Consultation Fees. R.V., AbbVie, BMS, GlaxoSmithKline, Human Genome Sciences, Merck, Pfizer, Roche, UCB Pharma—Consultation Fees, Research Support. Table 1.Week 78 clinical, functional, and radiographic outcomes in patients who received continued ADA + MTX vs those who continued PBO + MTX or added open-label ADA following an inadequate response ADA + MTX, n/N (%)a PBO + MTX, n/N (%)b Outcome Week 26 Week 52 Week 78 Week 26 Week 52 Week 78 DAS28 (CRP) <3.2 246/466 (53) 304/465 (65) 303/465 (65) 139/460 (30)*** 284/460 (62) 300/460 (65) HAQ-DI <0.5 211/466 (45) 220/466 (47) 224/466 (48) 150/460 (33)*** 203/460 (44) 208/460 (45) ΔmTSS ≤0.5 402/462 (87) 379/445 (86) 382/443 (86) 330/459 (72)*** 318/440 (72)*** 318/440 (72)*** DAS28 (CRP) <3.2 + ΔmTSS ≤0.5 216/462 (47) 260/443 (59) 266/443 (60) 112/459 (24)*** 196/440 (45) 211/440 (48)*** DAS28 (CRP) <3.2 + HAQ-DI <0.5 + ΔmTSS ≤0.5 146/462 (32) 168/443 (38) 174/443 (39) 82/459 (18)*** 120/440 (27)*** 135/440 (31)** aIncludes patients from the ADA Continuation (n = 105) and OL ADA Carry On (n = 259) arms, as well as the proportional equivalent number of responders from the ADA Withdrawal arm (n = 102). bIncludes patients from the MTX Continuation (n = 112) and Rescue ADA (n = 348) arms. Last observation carried forward: DAS28 (CRP) and HAQ-DI; Multiple imputations: ΔmTSS. ***P < 0.001 and **iP < 0.01, respectively, for differences between initial treatments from chi-squar

Search for dark matter produced in association with bottom or top quarks in √s = 13 TeV pp collisions with the ATLAS detector

A search for weakly interacting massive particle dark matter produced in association with bottom or top quarks is presented. Final states containing third-generation quarks and miss- ing transverse momentum are considered. The analysis uses 36.1 fb−1 of proton–proton collision data recorded by the ATLAS experiment at √s = 13 TeV in 2015 and 2016. No significant excess of events above the estimated backgrounds is observed. The results are in- terpreted in the framework of simplified models of spin-0 dark-matter mediators. For colour- neutral spin-0 mediators produced in association with top quarks and decaying into a pair of dark-matter particles, mediator masses below 50 GeV are excluded assuming a dark-matter candidate mass of 1 GeV and unitary couplings. For scalar and pseudoscalar mediators produced in association with bottom quarks, the search sets limits on the production cross- section of 300 times the predicted rate for mediators with masses between 10 and 50 GeV and assuming a dark-matter mass of 1 GeV and unitary coupling. Constraints on colour- charged scalar simplified models are also presented. Assuming a dark-matter particle mass of 35 GeV, mediator particles with mass below 1.1 TeV are excluded for couplings yielding a dark-matter relic density consistent with measurements

Microbeam Analysis in Combating Smuggling of Nuclear Materials

see attachmentJRC.E.3-Materials researc

Recent Experience in Nuclear Forensic Science

Aims: at identifying suspect individualusinginformation adherent to the pieces of evidenceJRC.E.8-Nuclear safeguards and Securit

Recent Advances in Nuclear Forensic Science

Nuclear forensics has been established as a new branch in science with the continued reporting of seizures of nuclear material and the need for identifying its origin. By today, the IAEA recorded more than 1000 illicit incidents involving nuclear or other radioactive materials [1]. Once illicitly trafficked nuclear material has been intercepted, the questions of its intended use and origin are to be addressed. Especially the origin is of prime importance in order to close the gaps and improve the physical protection at the sites where the theft or diversion occurred. To answer the questions, a dedicated nuclear forensics methodology has been developed. In this paper, the latest challenges will be described. Selected examples shall illustrate the complexity associated with this work. In particular, the need for reference data, for comparison samples will be highlighted, moreover the importance of definition of crime scene procedures and agreed protocols will be underlined. Finally, it has to be noted, that forensics awareness and dedicated training of all actors involved are essential for successful forensic analysis and for possible attribution of the nuclear material.JRC.E.8-Nuclear safeguards and Securit

Internal Conversion in Energy Dispersive X-Ray Analysis of Actinide-containing Materials

The use of X-ray elemental analysis tools like energy dispersive X-ray EDS is described in them context of the investigation of nuclear materials. These materials contain radioactive elements, particularly alpha-decaying actinides that affect the quantitative EDS measurement by producing interferences in the X-ray spectra. These interferences originating from X-ray emission are the result of internal conversion by the daughter atoms from the alpha-decaying actinides. The strong interferences affect primarily the L X-ray lines from the actinides in the typical energy range used for EDS analysis and would require the use of the M lines. However, it is typically at the energy of the actinide’s M lines that the interferences are dominant. The artifacts produced in the X-ray analysis are described and illustrated by some typical examples of analysis of actinidebearing material.JRC.E.3-Materials researc

Brazilian Validation of the Attachment to God Inventory (IAD-Br)

Bowlby’s Attachment Theory proposes that the person seeks protection and security with his or her caregiver, establishing a significant bond, which Bowlby characterizes as “attachment relationship”. The relationship with God can also be understood as an attachment relationship. Until now, there are no instruments in Brazil to measure one’s attachment to God. The purpose of this article is to present the adaptation and validation process of the Attachment to God Inventory for the Brazilian context, resulting in a Brazilian version of the Attachment to God Inventory (IAD-Br). The validation methodology for the IAD-Br consisted of Portuguese translation, reverse translation to English, pre-test, data collection, and validation through confirmatory factorial analysis (CFA). A total of 470 people participated in the study: 179 men and 291 women. Confirmatory factorial analysis presented unsatisfactory statistical parameters. Of the 28 items of the instrument, 11 items did not present adequate Item-Total Correlation. After excluding these 11 items, the instrument presented adequate adjustment indices. The IAD-Br, composed of 17 items, is able to be used to measure attachment to God in Brazil and constitutes a relevant instrument to identify the attachment to God style, being useful for application in the psychotherapeutic clinic and in contexts of spiritual care